RxDoctor Payments DataLook up a doctor →

KEDRAB: payments to doctors

Payments that named KEDRAB as the associated drug or biological, reported under the Sunshine Act for program years 20192025.

Total reported
$371K
Providers
1,377
Transactions
2,040
Average per transaction
$182

The per-transaction average — $182 — is the number that tells you what kind of spending this is. A few dollars means meals at product presentations, reported by the thousand. Hundreds or thousands means consulting, speaking or royalty arrangements with a much smaller group of physicians. Across all 1,377 providers the average total is $270, but that average hides a very steep distribution.

Companies reporting these payments

CompanyTotal reportedShare
Kedrion Biopharma, Inc.$267,55772.1%
Kedrion Biopharma Inc.$103,73227.9%
← All drugs & devices